Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -142.06% is 100% below its 5-year average of -71.17%, near the low end of its 5-year range (-142.06%–-17.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.27% below its 12-month average of -97.12%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -142.06%.
RETURN ON INVESTED CAPITAL (ROIC)
-142.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-97.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-86.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-71.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-46.27%
CURRENT VS 3Y AVG
-64.63%
CURRENT VS 5Y AVG
-99.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-298.55%
vs the sector median at left
Tenaya Therapeutics, Inc.
Market Cap
$120.26M
Return on Invested Capital (ROIC)
-142.06%
TTM Avg
-97.12%
3Y Avg
-86.29%
5Y Avg
-71.17%
Market Cap
$119.81M
Return on Invested Capital (ROIC)
-50.67%
TTM Avg
-131.41%
3Y Avg
-97.53%
5Y Avg
-74.13%
Market Cap
$120.92M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
Market Cap
$121.78M
Return on Invested Capital (ROIC)
-28.87%
TTM Avg
-28.06%
3Y Avg
-25.36%
5Y Avg
-20.47%
Market Cap
$117.89M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
Market Cap
$122.13M
Return on Invested Capital (ROIC)
-17.99%
TTM Avg
-23.22%
3Y Avg
-53.77%
5Y Avg
-63.92%
Market Cap
$119.26M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
Market Cap
$116.35M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$123.54M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | $120.26M | -142.06% | -97.12% | -86.29% | -71.17% |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.81M | -50.67% | -131.41% | -97.53% | -74.13% |
| enGene Holdings Inc. (ENGN)vs › | $120.92M | -1.78% | -41.34% | -32.26% | -28.21% |
| Seer, Inc. (SEER)vs › | $121.78M | -28.87% | -28.06% | -25.36% | -20.47% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $117.89M | -61.84% | -30.30% | -57.06% | -116.42% |
| Cibus, Inc. (CBUS)vs › | $122.13M | -17.99% | -23.22% | -53.77% | -63.92% |
| BGM Group Ltd. (BGM)vs › | $119.26M | -3.19% | -2.23% | -1.75% | 1.24% |
| Coya Therapeutics, Inc. (COYA)vs › | $116.35M | -0.05% | -44.27% | -81.25% | -78.53% |
| TuHURA Biosciences, Inc. (HURA)vs › | $123.54M | -137.40% | -133.78% | -372.93% | -315.43% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.48M | -74.08% | -72.79% | -71.36% | -64.12% |
ROIC
-142.1%
ROE
-148.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -142.06% |
| 2026-03-31 | -72.58% |
| 2025-12-31 | -70.98% |
| 2025-09-30 | -105.93% |
| 2025-06-30 | -94.05% |
| 2025-03-31 | -84.53% |
| 2024-12-31 | -111.53% |
| 2024-09-30 | -98.66% |
| 2024-06-30 | -84.73% |
| 2024-03-31 | -79.18% |
| 2023-12-31 | -88.77% |
| 2023-09-30 | -77.17% |
| 2023-06-30 | -67.39% |
| 2023-03-31 | -56.71% |
| 2022-12-31 | -49.32% |
| 2022-09-30 | -56.20% |
| 2022-06-30 | -43.95% |
| 2022-03-31 | -34.62% |
| 2021-12-31 | -24.90% |
| 2021-09-30 | -17.91% |
| 2021-06-30 | -33.39% |
| 2021-03-31 | -27.79% |
| 2020-12-31 | -27.19% |
